Skip Navigation LinksHome > August 2012 - Volume 34 - Issue 6 > Selective Ophthalmic Arterial Infusion of Chemotherapeutic D...
Journal of Pediatric Hematology/Oncology:
doi: 10.1097/MPH.0b013e318253f09e
Online Articles: Original Articles

Selective Ophthalmic Arterial Infusion of Chemotherapeutic Drugs for Recurrent Retinoblastoma

Trinavarat, Adisak MD*; Chiewvit, Pipat MD; Buaboonnam, Jassada MD; Sanpakit, Kleebsabai MD; Atchaneeyasakul, La-ongsri MD*

Collapse Box

Abstract

Introduced in 1988 by Kaneko and colleagues, selective ophthalmic arterial infusion of chemotherapeutic drug has recently gained more interest among retinoblastoma experts worldwide. The report showed that the procedure could be repeated up to 12 treatments without serious side effects. We report a 4-year-old girl with bilateral retinoblastoma. The left eye was enucleated for the group E disease. The right eye started with 3 retinal tumors (group C) was treated with systemic chemotherapy plus local therapy. Seven months after the last cycle of chemotherapy, the tumor recurred close to the fovea. Systemic chemotherapy was reinitiated without success. To avoid aggressive cryotherapy and external-beam radiotherapy, selective ophthalmic arterial infusion of chemotherapeutic drugs was performed for 15 sessions. The tumor responded partially without evidence of drug-induced retinal toxicity by the electroretinogram. Minor irregularities of the inner wall of supraclinoid portion of the internal carotid artery were observed only at the sixth session. Narrowing of the vascular lumen occurred on the last 2 sessions. We demonstrate that this technique when performed repeatedly could result in the anatomic changes of the small blood vessel. Careful follow-up is necessary for early detection of any serious consequences.

© 2012 Lippincott Williams & Wilkins, Inc.

Login

Article Tools

Share

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.

Connect With Us

Twitter
twitter.com/JPHOonline

For additional oncology content, visit LWW Oncology Journals on Facebook.